SCHEMBL3133104

SCHEMBL3133104

CCCOc1ccc(S(=O)(=O)Cl)cc1C(=O)NCc1c(CCC)n[nH]c1C(N)=O

nearest known ligand 0.35

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CA2 P00918 1/20 0.35
CA4 P22748 1/20 0.35
LMNA P02545 2/20 0.35
MAPK1 P28482 1/20 0.35
RAB9A P51151 1/20 0.35
HTT P42858 1/20 0.35
S1PR3 Q99500 1/20 0.34
NAMPT P43490 2/20 0.33
RXFP1 Q9HBX9 1/20 0.33
MAPT P10636 1/20 0.32
HSD17B10 Q99714 1/20 0.32
PPARG P37231 1/20 0.32
NLRP3 Q96P20 1/20 0.32
PDE5A O76074 2/20 0.32
ADRA2A P08913 1/20 0.32
CYP2D6 P10635 1/20 0.32
CYP2C9 P11712 1/20 0.32
DRD2 P14416 1/20 0.32
TSHR P16473 1/20 0.32
DRD3 P35462 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7450580 0.94 LMNA (0.41) CA2CA4LMNAMAPK1RAB9A
SCHEMBL5740859 0.86 PTGS2 (0.42) CA2CA4LMNAMAPK1RAB9A
SCHEMBL3131080 0.84 MEN1 (0.47) LMNAMAPTHSD17B10ADRA2ATSHR
SCHEMBL7394851 0.82 LMNA (0.42) CA2CA4LMNAMAPK1RAB9A
SCHEMBL7450538 0.76 PDE5A (0.46) LMNAHTTPDE5AKCNH2MEN1
SCHEMBL22616413 0.74 LMNA (0.49) CA2LMNAMAPK1RAB9AHTT
SCHEMBL7450573 0.73 HSD17B10 (0.40) LMNAMAPK1RAB9AHTTRXFP1
SCHEMBL6806762 0.73 RXFP1 (0.38) LMNAMAPK1RAB9AS1PR3RXFP1
SCHEMBL1705329 0.73 TERT (0.61) LMNARAB9AHTTRXFP1MAPT
SCHEMBL4971761 0.72 LMNA (0.34) LMNAMAPK1RAB9AHTTS1PR3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2398804-A2 ACID ADDITION SALT OF UDENAFIL, PREPARATION METHOD THEREOF AND PHAMACEUTICAL COMPOSITION COMPRISING THE SAME Dong-A Pharm.Co., Ltd. (KR) 2011-12-28 EP disclosed
WO-2010095849-A2 ACID ADDITION SALT OF UDENAFIL, PREPARATION METHOD THEREOF AND PHAMACEUTICAL COMPOSITION COMPRISING THE SAME DONG-A PHARM. CO., LTD. (KR) 2010-08-26 WO disclosed
WO-2010013925-A2 PHARMACOLOGICAL COMPOSITION FOR PREVENTION AND TREATMENT OF RESPIRATORY DISEASE CONTAINING PYRAZOLOPYRIMIDINONE COMPOUND OR PHARMACEUTICALLY ACCEPTABLE SALTS THEREOF DONG-A PHARMACEUTICAL. CO., LTD. (KR) 2010-02-04 WO disclosed
EP-1888074-A1 AGENT FOR THE PREVENTION AND TREATMENT OF LIVER DISEASES CONTAINING PYRAZOLOPYRIMIDINE DERIVATIVE Dong-A Pharmaceutical Co., Ltd. (KR) 2008-02-20 EP disclosed
WO-2007114534-A1 AGENT FOR THE PREVENTION AND TREATMENT OF PROSTATIC HYPERPLASIA COMPRISING PYRAZOLOPYRIMIDINONE COMPOUND DONG-A PHARMACEUTICAL.CO., LTD. (KR) 2007-10-11 WO disclosed
WO-2006132460-A1 AGENT FOR THE PREVENTION AND TREATMENT OF LIVER DISEASES CONTAINING PYRAZOLOPYRIMIDINE DERIVATIVE DONG-A PHARMACEUTICAL.CO., LTD. (KR) 2006-12-14 WO disclosed
EP-1299389-B1 A PROCESS FOR PREPARING PYRAZOLOPYRIMIDINONE DERIVATIVES FOR THE TREATMENT OF IMPOTENCE DONG A PHARM CO LTD (KR) 2006-10-04 EP disclosed
EP-1299389-A4 A PROCESS FOR PREPARING PYRAZOLOPYRIMIDINONE DERIVATIVES FOR THE TREATMENT OF IMPOTENCE DONG A PHARM CO LTD (KR) 2005-02-02 EP disclosed
EP-1299389-A1 A PROCESS FOR PREPARING PYRAZOLOPYRIMIDINONE DERIVATIVES FOR THE TREATMENT OF IMPOTENCE Dong A Pharmaceutical Co. Ltd. (KR) 2003-04-09 EP disclosed
WO-2001098304-A1 A PROCESS FOR PREPARING PYRAZOLOPYRIMIDINONE DERIVATIVES FOR THE TREATMENT OF IMPOTENCE DONG A PHARM. CO., LTD. (KR) 2001-12-27 WO disclosed